"Our mission also seeks to bring the advances made in clinical research with the individual patients to the population also suffering from these chronic diseases. Through this mission of partnering with the individual patient suffering from chronic diseases such as Crohn's disease, Ulcerative Colitis, C DIFF and low testosterone."

During the past decade, DiGiovanna Institute for Medical Education And Research conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DiGiovanna Institute for Medical Education And Research" #1 sponsor was "AstraZeneca" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DiGiovanna Institute for Medical Education And Research" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "DiGiovanna Institute for Medical Education And Research" are "Cardiovascular Disease" (4 trials), "Crohn Disease" (4 trials), "Type 2 Diabetes" (4 trials), "Colorectal Cancer" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "DiGiovanna Institute for Medical Education And Research" in a lesser frequency.

Most popular intervention types in "DiGiovanna Institute for Medical Education And Research" are "Drug" (17 trials), "Other" (5 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Dapagliflozin" (3 trials), "Ozanimod" (3 trials), "bococizumab (PF-04950615)" (2 trials) and "Blood Sample Collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "DiGiovanna Institute for Medical Education And Research" are 23 trials for "All" genders.

Currently, there are NaN active trials in "DiGiovanna Institute for Medical Education And Research". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in DiGiovanna Institute for Medical Education And Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in DiGiovanna Institute for Medical Education And Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".